Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Cenegermin Nasal Spray for Safety and Tolerability in Children with Spastic Cerebral Palsy
ItalyA study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.
ItalyStudy of GS-4321 for Healthy People and Patients With Chronic Hepatitis Delta Virus Infection
ItalyA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
ItalyStudy of STK-012 Alone and Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
ItalyStudy of ubamatamab alone or with cemiplimab for adults with ovarian, fallopian tube, peritoneal, or endometrial cancer that has come back
ItalyTesting MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment
ItalyStudy of oral cladribine compared to placebo for patients with generalized myasthenia gravis
ItalyA study testing how well patiromer lowers high potassium levels in the blood in children under 12 years of age with hyperkalemia
ItalyA Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
ItalyStudy comparing datopotamab deruxtecan with or without durvalumab to chemotherapy with pembrolizumab for patients with triple-negative breast cancer
ItalyA study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
